IFNG and fibrosarcoma: Preclinical studies with syngeneic mice injected with fibrosarcoma cells engineered to be insensitive to IFNγ demonstrated increased tumorigenicity versus their IFNγ-sensitive counterparts, inferring a role for this molecule in tumor cell immunogenicity, recognition and elimination [9].